Global Pharmaceuticals & Biotech Most Popular Stocks

BrightPath Biotherapeutics

Market Cap: JP¥6.3b

Engages in the development of cancer immunotherapy drugs in Japan.

U-Neuron Biomedical

Market Cap: NT$1.3b

Engages in the research and development of cell therapy technology and products in Taiwan.

Modalis Therapeutics

Market Cap: JP¥6.3b

Engages in the research and development of therapeutics to treat patients with serious genetic disorders.

Prince Pharmaceutical

Market Cap: NT$1.3b

Manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally.

NeoCore Technology

Market Cap: NT$1.3b

Designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices.

Elutia

Market Cap: US$42.1m

A commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation and breast reconstruction in the United States.

Neurizon Therapeutics

Market Cap: AU$64.0m

A clinical stage biotechnology company, develops therapeutics for neurodegenerative diseases.

Covalon Technologies

Market Cap: CA$58.4m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

IMGTLtd

Market Cap: ₩59.0b

Engages in researching and developing of an ultrasound-guided therapy technology for genetic therapy and drug delivery systems.

Techno Drugs

Market Cap: ৳5.1b

Manufactures and sells human and veterinary medicines in Bangladesh and internationally.

LAVA Therapeutics

Market Cap: US$41.8m

Operates as a clinical-stage immuno-oncology company that focuses on developing cancer treatments.

Taiwan Advance Bio-Pharmaceutical

Market Cap: NT$1.3b

Operates in the biotechnology industry in China Germany, USA, Italy, Malaysia, Vietnam, Thailand, Indonesia, Japan, Korea, India, Pakistan, and internationally.

Norda

Market Cap: NOK 415.7m

A biotechnology company, engages in the cancer diagnostic activities.

Cheilbio

Market Cap: ₩56.2b

Cheilbio Co., Ltd. produces and sells veterinary products for pig, cattle, chicken, aqua, and other animals in South Korea.

Tempest Therapeutics

Market Cap: US$41.6m

A clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.

Malin

Market Cap: €35.5m

Through its subsidiaries, operates in the life sciences industry in Ireland and the United States.

Eutilex.Co.Ltd

Market Cap: ₩58.4b

Engages in the discovery and development of immunomodulatory antibody therapeutics to treat cancers and autoimmune diseases.

Eone Diagnomics Genome Center

Market Cap: ₩57.4b

Provides genetic information analysis services in South Korea.

PRISM BioLabLTD

Market Cap: JP¥6.2b

A biotechnology company, discovers and develops small molecule inhibitors of protein-protein interaction targets utilizing proprietary PepMetics technology for treating patients suffering from cancer, autoimmune, fibrosis, and other diseases.

Talphera

Market Cap: US$41.3m

A specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings.

Molecure

Market Cap: zł150.5m

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for the treatment of neoplastic and inflammatory diseases in Poland.

Xilio Therapeutics

Market Cap: US$41.2m

A clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies.

Vidipha Central Pharmaceutical

Market Cap: ₫1.1t

Produces and sells pharmaceutical products under the Vidipha brand.

Tryptamine Therapeutics

Market Cap: AU$61.9m

A clinical-stage pharmaceutical development company, focuses on developing formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs in Australia, Canada, Switzerland, and the United States.

Generation Bio

Market Cap: US$40.4m

A biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells.

Nippon Chemiphar

Market Cap: JP¥6.0b

Engages in the manufacture, sale, import, and export of ethical pharmaceuticals and diagnostic agents in Japan and internationally.

ZIM Laboratories

Market Cap: ₹3.6b

Engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally.

Anxo Pharmaceutical

Market Cap: NT$1.2b

A specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally.

Hayat Pharmaceutical Industries

Market Cap: د.أ28.5m

Engages in the manufacture and marketing of generic pharmaceutical products in Jordan.

Genetic Signatures

Market Cap: AU$61.3m

Operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas.

Seoulin BioscienceLtd

Market Cap: ₩56.2b

A bio healthcare company, provides solutions in life sciences and healthcare primarily in South Korea.

CollPlant Biotechnologies

Market Cap: US$39.9m

A regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally.

Dyadic International

Market Cap: US$39.8m

A biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally.

MYUNGMOON PharmLtd

Market Cap: ₩55.7b

Engages in the research, development, production, distribution, and sale of pharmaceuticals in South Korea and internationally.

Apollomics

Market Cap: US$39.6m

A clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer.

C&R Research

Market Cap: ₩55.7b

n/a